Genetic Signatures Limited
ASX:GSS.AX
Overview | Financials
Company Name | Genetic Signatures Limited |
Symbol | GSS.AX |
Currency | AUD |
Price | 0.675 |
Market Cap | 146,332,540 |
Dividend Yield | 0% |
52-week-range | 0.38 - 0.85 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. John R. Melki BSc, Ph.D. |
Website | https://www.geneticsignatures.com |
An error occurred while fetching data.
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD